Jacobi Capital Management’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.01M Buy
40,050
+10,286
+35% +$259K 0.05% 308
2026
Q1
$752K Buy
29,764
+3,949
+15% +$101K 0.04% 337
2025
Q4
$659K Buy
25,815
+3,702
+17% +$94.7K 0.04% 348
2025
Q3
$567K Buy
22,113
+3,880
+21% +$98.5K 0.03% 370
2025
Q2
$461K Buy
18,233
+1,159
+7% +$28.8K 0.03% 400
2025
Q1
$427K Buy
17,074
+1,534
+10% +$37.9K 0.03% 400
2024
Q4
$382K Buy
15,540
+4,980
+47% +$125K 0.03% 407
2024
Q3
$272K Buy
+10,560
New +$267K 0.02% 481

Other funds holding IBDX

Jacobi Capital Management's IBDX Position: Q2 2026 in Review

Jacobi Capital Management increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 35% in Q2 2026, buying an estimated $259K and bringing the position to 40,050 shares worth $1.01M. The position accounts for 0.05% of the portfolio, ranked #308.

Jacobi Capital Management first reported a position in IBDX in Q3 2024 and has held it in 8 quarters since. 109 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • Jacobi Capital Management held 40,050 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $1.01M as of Q2 2026.
  • Jacobi Capital Management bought 10,286 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $259K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 0.05% of Jacobi Capital Management's portfolio in Q2 2026, its #308 holding.
  • Jacobi Capital Management first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q3 2024 and has held it in 8 quarters since.
  • 109 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Jacobi Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.